About
We’re developing the world’s first continuous multi-metabolite monitoring (CMM®) system for people living with chronic diseases.
Chronic Disease Management
1 in 3 people worldwide suffer from chronic conditions, leading to approximately 41 million deaths per year.
Product
Our integrated sensor is based on proven silicon photonics technologies, allowing us to miniaturize established spectroscopic analysis techniques into a small implantable device.
Lighting up the lives of people living with chronic disease
Chronic disease is the defining health crisis of our time and is predicted to rise at a growth rate of 100% by 2050. For those affected by a chronic disease, their medical needs remain unmet with sufferers reporting high levels of pain, discomfort, and an unnecessarily poor quality of life.
Indigo is developing a single sensor that is designed to measure a large number of metabolites. The small CMM® sensor is implanted just under the skin and continuously measures metabolites in the body delivering best-in-class data to aid the management of chronic diseases.
The Indigo receiver displays trends, values, and warnings in real-time on the user’s smartphone or any other connected device via the Indigo app. Users will be able to share their data with others, and for further analysis.
The inconspicuous Indigo CMM® sensor is being developed initially for diabetes management through continuous glucose, ketone, and lactate monitoring. Beyond diabetes, the CMM® has broad applicability due to the wide spectrum of metabolites it can monitor. Further opportunities include the management of chronic kidney disease as well as oncology, cardiovascular disease and athletic performance.
Join Our Growing Team
Indigo offers a unique opportunity to develop your talent in a dynamic and fast-growing company by building our next-generation CMM® system.
As part of Indigo’s international team of experts, you will contribute to bringing Indigo’s cutting-edge solution to the market and to improving the lives of people with chronic diseases.
Latest News And Events
Indigo reaffirms ISO 13485 certification from TÜV Süd
Indigo is pleased to announce the successful completion of its annual EN ISO 13485:2016 surveillance audit, conducted by TÜV SÜD, reaffirming its certification for the design and development of biomarker sensing devices and services. This certification emphasizes the...
Indigo Secures Patent for Groundbreaking Personal Health Monitoring System
Indigo has been granted U.S. Patent No. 11,992,310 for its personal health monitoring system. This revolutionary technology is designed to enhance continuous health monitoring by using a minimally invasive insertable sensor to track critical parameters like glucose...
Indigo’s closure of SHINE Clinical Trial
Indigo closed its SHINE clinical trial, marking a significant milestone in the development of innovative healthcare technology. The trial, designed to evaluate the longer-term stability of Indigo’s continuous multi-metabolite (‘CMM’) device, has concluded its phase...
“We are proud to pioneer groundbreaking technology that will have a positive impact on the life of millions of people living with chronic diseases.”
Danaë Delbeke
CEO and Founder